SOAT1 and gastric cancer: Exosomes, with the help of STAT pathways, could be a novel intermediate in the part of MSCs in GC promotion, and MSC-derived exosomes may be an unexplored therapeutic target not only for GC and ovarian cancer treatment but also for novel diagnostics of Lynch syndrome [46,76,78,79,80].